SCHEMBL1313014

SCHEMBL1313014

C1CC2OC2CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16398272 0.75
SCHEMBL20136626 0.75
SCHEMBL16398274 0.75
SCHEMBL578911 0.75
SCHEMBL7268795 0.73
SCHEMBL9867808 0.73
Oxirane SCHEMBL5379132 0.72
SCHEMBL24611594 0.71
SCHEMBL24903863 0.71
SCHEMBL21910448 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594835-A4 METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES AUSPEX PHARMACEUTICALS INC (US) 2007-05-02 EP claimed
EP-1594835-A2 METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES Auspex Pharmaceuticals, Inc. (US) 2005-11-16 EP claimed
WO-2004064745-A2 METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES AUSPEX PHARMACEUTICALS, INC. (US) 2004-08-05 WO claimed
EP-0002046-B1 PROCESS FOR THE PREPARATION OF (1S,2S,6R)-2-METHYL-3,7-DIOXABICYCLO(4,1,0)HEPTAN-4-OL AND ITS METHYL ETHER F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-02-10 EP claimed
US-12583858-B2 TDO2 inhibitors GENENTECH, INC. (US) 2026-03-24 US disclosed
US-20260049092-A1 ANTIBACTERIAL COMPOUNDS BLACKSMITH MEDICINES INC (US) 2026-02-19 US disclosed
US-20250382305-A1 COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 PTC THERAPEUTICS INC (US) 2025-12-18 US disclosed
EP-4619397-A1 SALT-INDUCIBLE KINASES (SIK) INHIBITORS AND METHODS OF USES THEREOF Insilico Medicine IP Limited (HK) 2025-09-24 EP disclosed
US-12410262-B2 Peptide conjugates of cytotoxins as therapeutics Cybrexa 2, Inc. (US) 2025-09-09 US disclosed
EP-4568955-A1 ANTIBACTERIAL COMPOUNDS Blacksmith Medicines, Inc. (US) 2025-06-18 EP disclosed
WO-2025106644-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF ALPHA-V BETA-1 INTEGRIN MORPHIC THERAPEUTIC, INC. (US) 2025-05-22 WO disclosed
US-12304902-B2 Hydroxyheterocycloalkane-carbamoyl derivatives IDORSIA PHARMACEUTICALS LTD (CH) 2025-05-20 US disclosed
WO-1999064414-A1 BENZAMIDES WITH TETRAHYDROFURANYLOXY SUBSTITUTENTS AS PHOSPHODIESTERASE 4 INHIBITORS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1999-12-16 WO disclosed
WO-1998050533-A1 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 1998-11-12 WO disclosed
US-4677211-A Preparation of lactones SANDOZ PHARMACEUTICALS CORP. (US) 1987-06-30 US disclosed
US-4625039-A 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediates SANDOZ PHARM. CORP. (US) 1986-11-25 US disclosed
US-4474971-A ANTICHOLESTEROL AGENTS, ATHEROSCLEROSIS SANDOZ, INC. (US) 1984-10-02 US disclosed
EP-0002046-B1 PROCESS FOR THE PREPARATION OF (1S,2S,6R)-2-METHYL-3,7-DIOXABICYCLO(4,1,0)HEPTAN-4-OL AND ITS METHYL ETHER F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1982-02-10 EP disclosed
US-4047963-A ETHYLENE OXIDE COPOLYMER, UNSATURATED MONOMER, PHOTOINITIATOR HERCULES INCORPORATED (US) 1977-09-13 US disclosed
US-4009128-A Polymerization of epoxides HERCULES INCORPORATED (US) 1977-02-22 US disclosed